A rise in incidence of motion sickness globally, advancements in the manufacturing and development of medications in the industry, and the rise in awareness about motion sickness prevention and medications drive the global motion sickness treatment market.
PORTLAND, Ore., March 28, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Motion Sickness Treatment Market by Drug Class (Antihistamines, Anticholinergics, Others), by Route of Administration (Oral, Others), by Distribution Channel (Hospital Pharmacies, Drug Store and Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global motion sickness treatment industry was valued at $393.70 million in 2025 and is estimated to generate $525 million by 2031, witnessing a CAGR of 2.9% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Request Sample, PDF Brochure - https://www.alliedmarketresearch.com/request-sample/13034
Drivers, Restraints, and Opportunities
A rise in incidence of motion sickness globally, advancements in the manufacturing and development of medications in the motion sickness treatment industry, the rise in awareness about motion sickness prevention and treatment medications, and advancements in the healthcare sector drive the motion sickness treatment market. However, the presence of alternate solutions for motion sickness treatment and limited awareness and knowledge about motion sickness are likely to hinder market growth during the forecast period. On the other hand, growth & innovations in the pharmaceutical industry regarding the manufacturing of motion sickness medications will present new growth opportunities for the global motion sickness treatment market in the coming years.
Impact of Covid-19 on Motion Sickness Treatment Market-
Procure Complete Report (263 Pages PDF with Insights, Charts, Tables, and Figures)
The antihistamines segment to dominate the market during the forecast period
Based on drug class, the antihistamines segment contributed to the largest share of nearly half of the global motion sickness treatment market in 2025 and is expected to maintain its dominance during the forecast period. This is owing to an increase in incidence of motion sickness among the travelling population. However, the anticholinergics segment is projected to witness the fastest CAGR of 3.3% from 2022 to 2031. This is because doctors are prescribing anticholinergics on a large scale to those experiencing motion sickness.
The oral segment to grab the lion's share during the forecast period
Based on route of administration, the oral segment grabbed the highest share of more than three-fifths of the motion sickness treatment market in 2025 and is expected to dominate the market in 2031. This is because there is a high demand for antihistaminic medications which are mainly available in tablet, capsule and pill dosage forms. The others segment, however would witness the fastest CAGR of 3.2% from 2022 to 2031, due to the increase in the adoption of scopolamine transdermal patches by travelers around the globe.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/13034
The drug store and retail pharmacies segment to grab the lion's share during the forecast period
Based on distribution channel, the drug store and retail pharmacies segment grabbed the highest share of more than two-thirds of the motion sickness treatment market in 2025 and is expected to dominate the market in 2031. This is owing to an increase in the number of drug stores and pharmacies around the globe. The online pharmacies segment, however would witness the fastest CAGR of 4.1% from 2022 to 2031, due to the easy accessibility of medications and doors step delivery services.
North America to garner the largest revenue by 2031
Based on region, the market in North America was the largest in 2025, accounting for more than two-fifths of the global motion sickness treatment market and is likely to maintain its dominance during the forecast timeframe. This is owing to the rise in number of travelers in this region, including tourist, business clients and others. The Asia-Pacific market, however, is likely to show the fastest CAGR of 3.8% during the forecast period. This is owing to factors such as rise in investments in manufacturing of high-quality products by major key players and the availability of raw materials for manufacturing of motion sickness treatment medications in the region.
Leading Market Players
The report analyzes these key players of the global motion sickness treatment market. These players have adopted various strategies such as expansion, new product launches, partnerships, and others to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, product portfolio, and developments by every market player.
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Surgical Drains Market by Product (Open surgical drainage system, Closed surgical drainage system), by Application (General Surgery, Cardiac & Thoracic Surgery, Orthopedic Surgery, Obstetric/Gynecological Surgery, Other Surgeries), by Type (Active Drains, Passive Drains), by End User (Hospitals, Ambulatory surgery centers (ASCs) & clinics): Global Opportunity Analysis and Industry Forecast, 2020-2030
Digestive Enzymes Market by Origin (Animal, Microbial, Plant), by Enzyme Type (Carbohydrase, Protease, Lipase, Other Enzyme Types), by Applications (Prescription Medicine, Sports Nutrition, Infant Nutrition): Global Opportunity Analysis and Industry Forecast, 2021-2031
Cancer Stem Cells Market by Cancer Forms (Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Others), by Application (Targeted Cancerous Stem Cells, Stem Cell-based cancer Therapy): Global Opportunity Analysis and Industry Forecast, 2021-2031
Animal Model Market by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Application (Drug Discovery & Development, Basic Research, and Others), and End User (Pharma & Biotech Companies, Academic Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
Leukapheresis Market by Product (Devices, Disposables), by Method (Centrifugation, Membrane Separation, Selective Adsorption), by Application (Therapeutic Applications, Research Applications), by End User (Blood Centers, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
These press releases may also interest you